| 1 |
35105352 | Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer's disease. | 2022 Feb 1 |
1 |
| 2 |
31168055 | Ganglioside deficiency in hypothalamic POMC neurons promotes body weight gain. | 2020 Feb |
3 |
| 3 |
29973867 | Deletion of Specific Sphingolipids in Distinct Neurons Improves Spatial Memory in a Mouse Model of Alzheimer's Disease. | 2018 |
2 |
| 4 |
27639375 | Lipid microdomain modification sustains neuronal viability in models of Alzheimer's disease. | 2016 Sep 17 |
2 |
| 5 |
26038579 | Fasting-Induced Lipolysis and Hypothalamic Insulin Signaling Are Regulated by Neuronal Glucosylceramide Synthase. | 2015 Oct |
2 |
| 6 |
23554574 | Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis. | 2013 |
2 |
| 7 |
21394236 | Niemann-Pick type C pathogenesis and treatment: from statins to sugars. | 2010 Jun 1 |
1 |
| 8 |
19745600 | The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. | 2009 Dec 31 |
1 |
| 9 |
11971858 | Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation. | 2002 Mar |
2 |
| 10 |
9809988 | Inhibition of hemopoiesis in vitro by neuroblastoma-derived gangliosides. | 1998 Nov 1 |
1 |
| 11 |
1827496 | Gangliosides inhibit glucosylceramide synthase: a possible role in ganglioside therapy. | 1991 Jun |
2 |